Wählen Sie die Sprache / Choose your language:
Aktuelle Termine


Institut für Virologie
am Department für Hygiene,
Mikrobiologie und Publich Health
der Medizinischen Universität Innsbruck

Peter-Mayr-Straße 4b
A-6020 Innsbruck

Tel.: 0512/9003-71701
Fax: 0512/9003-73701
E-Mail: virologie@i-med.ac.at
Publikationen Dr. Kimpel


Hombach AA, Görgens A, Chmielewski M, Murke F, Kimpel J, Giebel B, Abken H. Superior Therapeutic Index in Lymphoma Therapy: CD30+ CD34+ Hematopoietic Stem Cells Resist a Chimeric Antigen Receptor T-cell Attack. Mol Ther. 2016 Jun 28.

Zhou Q, Uhlig KM, Muth A, Kimpel J, Lévy C, Münch RC, Seifried J, Pfeiffer A, Trkola A, Coulibaly C, von Laer D, Wels WS, Hartwig UF, Verhoeyen E, Buchholz CJ. Exclusive Transduction of Human CD4+ T Cells upon Systemic Delivery of CD4-Targeted Lentiviral Vectors. J Immunol. 2015 Sep 1;195(5):2493-501.

Muik A, Stubbert LJ, Jahedi RZ, Geiβ Y, Kimpel J, Dold C, Tober R, Volk A, Klein S, Dietrich U, Yadollahi B, Falls T, Miletic H, Stojdl D, Bell JC, von Laer D. Re-engineering vesicular stomatitis virus to abrogate neurotoxicity, circumvent humoral immunity, and enhance oncolytic potency. Cancer Res. 2014 Jul 1;74(13):3567-78.

Tober R, Banki Z, Egerer L, Muik A, Behmüller S, Kreppel F, Greczmiel U, Oxenius A, von Laer D, Kimpel J. Viral Vector Vaccine VSV-GP Boosts Immune Response upon Repeated Applications. J Virol. 2014 May;88(9):4897-907.

Volk A, Hartmann S, Muik A, Geiß Y, Königs Chr, Dietrich U, von Laer D, Kimpel J. Modified Trimera mice, a new humanized mouse model for gene modified T cells, provide secondary lymphoid structures. J Gene Med. 2012 Aug;14(8):540-8.

Vets S, Kimpel J, Volk J, De Rijck J, Verbinnen B, Maes W, von Laer D, Debyser Z, Gijsbers R. LEDGF/p75 qualifies as an efficient target for HIV gene therapy in the NSG-mouse model. Mol Ther. 2012 May;20(5):908-17.

Egerer L, von Laer D, Kimpel J. Gene Therapy for HIV-1 Infection. Recent Translational Research in HIV/AIDS, ISBN 978-953-307-719-2, publishing date: November 2011

Newrzela S, Cornils K, Heinrich T, Schläger J , Yi J-H, Lysenko O, Kimpel J, Fehse B, von Laer D. Retroviral insertional mutagenesis can contribute to immortalization of mature T lymphocytes. Mol Med. 2011 Jul 27.

Egerer L, Volk A, Kahle J, Kimpel J, Brauer F, Hermann FG, von Laer D. Secreted Antiviral Entry Inhibitory (SAVE) Peptides for Gene Therapy of HIV Infection. Mol Ther. 2011 Mar 1.

Kimpel J, Braun SE, Qiu G, Wong FE, Conolle M, Schmitz JE, Brendel C, Humeau LM, Dropulic B, Rossi JJ, Berger A, von Laer D, Johnson RP. Survival of the fittest: positive selection of CD4+ T cells expressing a membrane-bound fusion inhibitor following HIV-1 infection. PLoS One. 2010 Aug 23;5(8):e12357.



Curriculum Vitae